Taysha Gene Therapies
TSHA
TSHA
129 hedge funds and large institutions have $290M invested in Taysha Gene Therapies in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+12
Holders Change %
+10.26%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
44
Reduced
27
Closed
15
Calls
$182K
Puts
$13K
Net Calls
+$169K
Net Calls Change
+$164K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$30.5M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
$18.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$8.65M |
| 4 |
State Street
Boston,
Massachusetts
|
$11.2M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
$11.4M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
$15M |
| 2 |
VA
VR Adviser
New York
|
$5.58M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$261K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$28.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$1.29M |
